Clinical Trial Update: Gemcitabine With Curcumin for Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine in combination with curcumin for pancreatic cancer has been completed. The study was sponsored by Rambam Health Care Campus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Curcumin (curcumin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED